Kuano ^Companies

Kuano is an organization that specializes in providing innovative quantum and AI solutions for drug discovery and design. Their main goal is to accelerate the development of better drug candidates through their discovery platform, which combines target quantum mapping and AI-led chemistry. With a focus on enzymatic franchises, Kuano collaborates with experts in the field, such as Augustin Amour, who brings 24 years of experience from GSK and expertise in immunology and molecular pharmacology. Kuano's achievements include contributing to over 50 publications and patents, as well as leading industry engagement with academia through advisory roles in organizations like the Biochemical Society's Industry Advisory Panel and the EU Openscreen consortium.